Evidence map›Paper›PMID 24741089›Full record

ArticleJournal of virology2014

Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.

Miriam Schieffer, Heiko K Jessen, Alexander F Oster, Franco Pissani, Damien Z Soghoian, Richard Lu, Arne B Jessen, Carmen Zedlack, Bruce T Schultz, Isaiah Davis and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Protein-dependent CD4iScience · 2026
    Article
  3. Article
  4. Cytotoxic CD4Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Miriam SchiefferHIV Clinic Praxis Jessen, Berlin, Germany Institute for Microbiology and Hygiene, Charité University Medical Center, Berlin, Germany.
Heiko K JessenHIV Clinic Praxis Jessen, Berlin, Germany.
Alexander F OsterU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Franco PissaniU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Damien Z SoghoianRagon Institute of MGH, MIT and Harvard, Cambridge, Massachussetts, USA.
Richard LuU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Arne B JessenHIV Clinic Praxis Jessen, Berlin, Germany.
Carmen ZedlackHIV Clinic Praxis Jessen, Berlin, Germany.
Bruce T SchultzU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Isaiah DavisHIV Clinic Praxis Jessen, Berlin, Germany.
Srinika RanasingheRagon Institute of MGH, MIT and Harvard, Cambridge, Massachussetts, USA.
Eric S RosenbergMassachussetts General Hospital, Boston, Massachussetts, USA.
Galit AlterRagon Institute of MGH, MIT and Harvard, Cambridge, Massachussetts, USA.
Ralf R SchumannInstitute for Microbiology and Hygiene, Charité University Medical Center, Berlin, Germany.
Hendrik StreeckU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachussetts, USA hstreeck@hivresearch.org.
Walter Reed Army Institute of Research · USOrthopädische Praxis · DERagon Institute of MGH, MIT and Harvard · USCharité - Universitätsmedizin Berlin · DEMassachusetts General Hospital · US

Funding

Recognition of HIV-1 by Innate Immunity Receptors during Primary InfectionP01AI074415 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2008 to 2013
$17.3M
Modulation of HIV-specific CD8+ T and B cell function by CD4+ T helper responsesR01AI091450 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI STREECK, HENDRIK · 2010 to 2013
$1.7M
T follicular helper cells: Role in generation of anti-HIV antibody responsesR01AI094602 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI STREECK, HENDRIK · 2011 to 2015
$1.6M
NIAID NIH HHS P01 AI074415NIAID NIH HHS R01 AI091450NIAID NIH HHS R01 AI091450-01NIAID NIH HHS R01 AI094602NIAID NIH HHS R01 AI094602-01
6 · The paper itself

Abstract

unlabelledEffector CD4 T cell responses have been shown to be critically involved in the containment and clearance of viral pathogens. However, their involvement in the pathogenesis of HIV infection is less clear, given their additional role as preferred viral targets. We previously demonstrated that the presence of HIV-specific CD4 T cell responses is somewhat associated with HIV control and that specific CD4 T cell functions, such as direct cytolytic activity, can contribute to control of HIV viremia. However, little is known about how the induction of HIV-specific CD4 T cell responses during acute HIV infection influences disease progression and whether responses induced during the early phase of infection are preferentially depleted. We therefore longitudinally assessed, in a cohort of 55 acutely HIV-infected individuals, HIV-specific CD4 T cell responses from acute to chronic infection. Interestingly, we found that the breadth, magnitude, and protein dominance of HIV-specific CD4 T cell responses remained remarkably stable over time. Moreover, we found that the epitopes targeted at a high frequency in acute HIV infection were recognized at the same frequency by HIV-specific CD4 T cells in chronic HIV infection. Interestingly the induction of Gag-specific CD4 T cell responses in acute HIV infection was significantly inversely correlated with viral set point in chronic HIV infection (R = -0.5; P = 0.03), while the cumulative contribution of Env-specific CD4 T cell responses showed the reverse effect. Moreover, individuals with HIV-specific CD4 T cell responses dominantly targeting Gag over Env in acute HIV infection remained off antiretroviral therapy significantly longer (P = 0.03; log rank). Thus, our data suggest that the induction of HIV-specific CD4 T cell responses during acute HIV infection is beneficial overall and does not fuel disease progression. IMPORTANCE: CD4 T cells are critical for the clearance and control of viral infections. However, HIV preferentially infects HIV-specific CD4 T cells. Thus, their contribution to the control of HIV viremia is uncertain. Here, we study HIV-specific CD4 T cell responses from acute to chronic HIV infection and show that the generation of certain CD4 responses is associated with control rather than disease progression.

Indexed as

Acute DiseaseAmino Acid SequenceAntiviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesChronic DiseaseDisease ProgressionHIV-1HIV InfectionsHIV SeropositivityHumansImmunodominant EpitopesLongitudinal StudiesLymphocyte ActivationMolecular Sequence DataViral LoadAntiviral AgentsImmunodominant Epitopes

Identifiers

PMID24741089
PMCPMC4054446
OpenAlexW2128161673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.